M
Mercè Brunet
Researcher at University of Barcelona
Publications - 103
Citations - 4090
Mercè Brunet is an academic researcher from University of Barcelona. The author has contributed to research in topics: Transplantation & Tacrolimus. The author has an hindex of 30, co-authored 98 publications receiving 3369 citations. Previous affiliations of Mercè Brunet include Carlos III Health Institute.
Papers
More filters
Journal ArticleDOI
Total and metallothionein-bound cadmium in the liver and the kidney of a population in Barcelona (Spain).
TL;DR: Evaluated the concentration of cadmium in the kidney and the liver in the urban general population of Barcelona and metallothionein was assessed in both tissues since it is well known that this protein plays a crucial role in cadMium kinetics and toxicity.
Journal ArticleDOI
Influence of posttransplant time on dose and concentration of tacrolimus in liver transplant patients
TL;DR: The decrease in corticosteroid doses and the increase in serum albumin may explain the reduction in clearance with time.
Journal ArticleDOI
High frequency of central memory regulatory T cells allows detection of liver recipients at risk of early acute rejection within the first month after transplantation
Francisco Boix-Giner,Olga Millán,David San Segundo,Pedro Muñoz-Cacho,Esther Mancebo,Santiago Llorente,Lourdes Rafael-Valdivia,Antoni Rimola,Emilio Fábrega,Anna Mrowiec,Luis M. Allende,Alfredo Minguela,Jose Miguel Bolarín,Estela Paz-Artal,Marcos López-Hoyos,Mercè Brunet,Manuel Muro +16 more
TL;DR: A prediction model for assessing risk of AR is developed that can provide clinicians with useful information for managing patients individually and customizing immunosuppressive therapies.
Journal ArticleDOI
T-cell function monitoring in stable renal transplant patients treated with sirolimus monotherapy.
TL;DR: The results suggest an association between low ATP and IL-10 concentrations and the presence of infection and sequential measurement of these biomarkers in stable renal transplant recipients treated with monotherapy could be useful to evaluate the biological effect of sirolimus in each patient and to establish personalized therapy taking into account the individual response to the drug.
Journal ArticleDOI
Measuring Intracellular Concentrations of Calcineurin Inhibitors: Expert Consensus from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Expert Panel.
Florian Lemaitre,Nils Tore Vethe,Antonio D'Avolio,Camille Tron,Ida Robertsen,Brenda C. M. de Winter,Amedeo Denicolo,Birgit C. P. Koch,Raman Venkataramanan,Teun van Gelder,Mercè Brunet,Stein Bergan,Stein Bergan,Dennis A. Hesselink,Pierre Wallemacq +14 more
TL;DR: A group of leading investigators in this field have shared experiences and have presented pre-analytical and analytical recommendations for measuring intracellular CNI concentrations, and standardization appears essential in this area.